Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hospital of ChinaHKSE:03869 73 FCF Margin % is 14.57% as of Dec. 2025, which is 9% below its 10-year median of 16.00. GuruFocus rates HKSE:03869 with a GF Score™ of 73/100 and a GF Value™ of HK$5.53 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 671 Healthcare Providers & Services companies, Hospital of China ranks better than 70.79% on this metric.
The historical rank and industry rank for Hospital of China's FCF Margin % or its related term are showing as below:
HKSE:03869'
s FCF Margin % Range Over the Past 10 Years
Min: 4.81 Med: 16 Max: 116.74
Current: 9.25
During the past 12 years, the highest FCF Margin % of Hospital of China was 116.74%. The lowest was 4.81%. And the median was 16.00%.
HKSE:03869's FCF Margin % is ranked better than 70.79% of 671
companies
in the Healthcare Providers & Services industry
Industry Median: 3.15
vs HKSE:03869: 9.25
The historical data trend for Hospital of China's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:03869 vs HCA, THC, EHC: FCF Margin % Comparison
For the Medical Care Facilities subindustry, Hospital of China's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hospital of China FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Hospital of China's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Hospital of China's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hospital of China (HKSE:03869) has a FCF Margin % of 14.57% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Hospital of China and its competitors. This is near median its historical median of 16.00. Over the past decade, Hospital of China's FCF Margin % has ranged from 4.81 to 116.74. According to the industry distribution chart, Hospital of China ranks #196 out of 671 companies in the Healthcare Providers & Services industry, placing it in the top 29.2%.
Is Hospital of China's FCF Margin % too high?
Hospital of China's current FCF Margin % of 14.57% is near median its 10-year median of 16.00. Over the past 10 years, this metric has ranged from a low of 4.81 to a high of 116.74. The Healthcare Providers & Services industry median FCF Margin % is 3.15. Hospital of China's value of 14.57% is 362.5% above this industry median. Based on the distribution chart, Hospital of China ranks #196 out of 671 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Hospital of China has a GF Score™ of 73/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Hospital of China's FCF Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Hospital of China ranks #196 out of 671 companies for FCF Margin %. This puts Hospital of China in the upper half of its industry. The industry median FCF Margin % is 3.15. Hospital of China's value of 14.57% is 362.5% above this benchmark. Historically, Hospital of China's own FCF Margin % has ranged from 4.81 to 116.74 over the past decade. While the company's 10-year median is 16.00 vs. the industry median of 3.15, Hospital of China has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.15, based on 671 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hospital of China's current FCF Margin % of 14.57% is 362.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Hospital of China and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hospital of China's current FCF Margin % is 14.57%, which is near median its own 10-year median of 16.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hospital of China stock overvalued right now?
Based on GuruFocus' analysis, Hospital of China (HKSE:03869) is currently considered Possible Value Trap. The stock's GF Value™ is HK$5.53, compared to a current price of HK$3.40 — trading 38.5% below its estimated fair value. The current FCF Margin % is 14.57%, which is near median its 10-year median of 16.00 and 362.5% above the Healthcare Providers & Services industry median of 3.15. Hospital of China's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Hospital of China (HKSE:03869), the current FCF Margin % is 14.57% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hospital of China (HKSE:03869) Overvalued in 2026?
Based on GuruFocus' analysis, Hospital of China stock appears to be undervalued.
The current stock price of HK$3.40 is trading 38.5% below its estimated GF Value™ of HK$5.53.
GuruFocus considers Hospital of China to be Possible Value Trap.
Key valuation signals for HKSE:03869:
FCF Margin %: 14.57% (near median its 10-year median of 16.00)
GF Value™: HK$5.53 vs. price of HK$3.40 (38.5% below fair value)
Industry Position: 362.5% above the Healthcare Providers & Services median (#196 of 671)
No single metric tells the full story. See the HKSE:03869 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hospital Corporation of China Ltd is an investment holding company that operates and manages hospitals in the People's Republic of China. In addition to offering hospital management services, it also provides supply chain services, other ancillary services, and sells pharmaceutical products. The company has three operating segments, namely, Hospital management services, General hospital services, and the sale of pharmaceutical products. The General Hospital services segment is the primary revenue generator for the company. All the company's revenue is generates from PRC.
73GF Score
Get the complete analysis for HKSE:03869
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:03869 has been successfully added to your 
